Conversion to Alzheimer's disease dementia from normal cognition directly or with the intermediate mild cognitive impairment stage

被引:4
作者
Lu, Xinlin [1 ]
Zhang, Yahui [1 ]
Tang, Yichen [2 ]
Bernick, Charles [3 ]
Shan, Guogen [1 ]
机构
[1] Univ Florida, Dept Biostat, Gainesville, FL 32610 USA
[2] Zhejiang Univ City Coll, Sch Informat & Elect Engn, Hangzhou, Peoples R China
[3] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognitive decline; disease progression; functional impairment; mild cognitive impairment; neuropsychiatric symptoms; DATA SET UDS; EPIDEMIOLOGY;
D O I
10.1002/alz.14393
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTIONProgression to Alzheimer's disease (AD) dementia from normal cognition (NC) can follow different trajectories, with most progressing through a recognizable mild cognitive impairment stage (NC-MCI-AD), while some individuals transition quickly from NC to AD dementia (NC-AD). METHODSWe compared demographic characteristics, health factors, and cognitive and functional assessments across three time points: the first NC visit, the last NC visit, and the first AD dementia visit. RESULTSThe NC-MCI-AD group showed greater impairment in cognitive and functional scores at AD dementia diagnosis, despite maintaining better cognitive function during the NC stage. Analysis of yearly changes revealed negligible differences during NC. However, the yearly change during the AD dementia stage suggested potentially more rapid functional decline in the NC-AD group. DISCUSSIONThese findings highlight the heterogeneity in AD disease progression and emphasize the importance of considering diverse progression patterns in AD research and clinical practice. Highlights We investigated the disease progression difference between patients who converted to Alzheimer's disease (AD) dementia from normal cognition (NC) directly or through the mild cognitive impairment (MCI) stage. We found that the NC-MCI-AD group showed greater impairment in cognitive and functional scores at AD dementia diagnosis. We discovered that the NC-AD group had rapid functional decline once patients were confirmed with AD onset.
引用
收藏
页数:14
相关论文
共 28 条
[1]   Obesity as a risk factor for Alzheimer's disease: weighing the evidence [J].
Alford, S. ;
Patel, D. ;
Perakakis, N. ;
Mantzoros, C. S. .
OBESITY REVIEWS, 2018, 19 (02) :269-280
[2]   Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) [J].
Arevalo-Rodriguez, Ingrid ;
Smailagic, Nadja ;
Roque i Figuls, Marta ;
Ciapponi, Agustin ;
Sanchez-Perez, Erick ;
Giannakou, Antri ;
Pedraza, Olga L. ;
Bonfill Cosp, Xavier ;
Cullum, Sarah .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03)
[3]   The National Alzheimer's Coordinating Center (NACC) database: The uniform data set [J].
Beekly, Duane L. ;
Ramos, Erin M. ;
Lee, William W. ;
Deitrich, Woodrow D. ;
Jacka, Mary E. ;
Wu, Joylee ;
Hubbard, Janene L. ;
Koepsell, Thomas D. ;
Morris, John C. ;
Kukull, Walter A. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (03) :249-258
[4]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[5]   Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis [J].
Bloom, George S. .
JAMA NEUROLOGY, 2014, 71 (04) :505-508
[6]   Comprehensive Review on Alzheimer's Disease: Causes and Treatment [J].
Breijyeh, Zeinab ;
Karaman, Rafik .
MOLECULES, 2020, 25 (24)
[7]   National estimates of the prevalence of Alzheimer's disease in the United States [J].
Brookmeyer, Ron ;
Evans, Denis A. ;
Hebert, Liesi ;
Langa, Kenneth M. ;
Heeringa, Steven G. ;
Plassman, Brenda L. ;
Kukull, Walter A. .
ALZHEIMERS & DEMENTIA, 2011, 7 (01) :61-73
[8]  
Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233
[9]   The Role of Apolipoprotein E in Alzheimer's Disease [J].
Kim, Jungsu ;
Basak, Jacob M. ;
Holtzman, David M. .
NEURON, 2009, 63 (03) :287-303
[10]   A review on Alzheimer's disease pathophysiology and its management: an update [J].
Kumar, Anil ;
Singh, Arti ;
Ekavali .
PHARMACOLOGICAL REPORTS, 2015, 67 (02) :195-203